StonvexLoading…
StonvexStonvexStonvexCore line items from LFMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $194.06M | $154.82M | $152.55M | $119.03M |
Operating Income | $-7.67M | $-20.40M | $-14.49M | $-43.45M |
Net Income | $14.35M | $-21.41M | $-20.60M | $-45.54M |
EPS (Diluted) | $0.25 | $-0.60 | $-0.70 | $-1.57 |
Total Assets | $70.41M | $76.10M | $58.48M | $25.67M |
Total Liabilities | $47.25M | $83.65M | $52.91M | $32.97M |
Cash & Equivalents | $36.79M | $35.00M | $33.15M | $3.96M |
Free Cash Flow OCF − CapEx | $6.41M | $16.05M | $8.62M | $-23.30M |
Shares Outstanding | 46.66M | 42.19M | 38.26M | 31.45M |